Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOPAH
2009-013897-42Phase 4Completed
- Sponsor
- University Hospital Southampton
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone and pentoxifylline in alcoholic hepatitis (AH) (4 arms), sponsored by University Hospital Southampton. Primary endpoint: Mortality rate at 28 days following start of treatment. Started Mar 2010; status: completed.
02
Drugs
prednisolonepentoxifylline
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on 2009-013897-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013897-42.